XML 40 R21.htm IDEA: XBRL DOCUMENT v3.19.1
Share-Based Compensation Plans and Capital Stock Transactions
12 Months Ended
Feb. 02, 2019
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Share-Based Compensation Plans and Capital Stock Transactions
SHARE-BASED COMPENSATION PLANS AND CAPITAL STOCK TRANSACTIONS:
General
In April 2017, the Board approved the Amended and Restated 2012 Omnibus Stock and Incentive Plan (the "Amended Omnibus Plan"), which replaced the Chico's FAS, Inc. 2012 Omnibus Stock and Incentive Plan, effective upon shareholder approval on June 22, 2017. The aggregate number of shares of our common stock that may be issued under the Amended Omnibus Plan (since inception) is 15.5 million shares plus any shares represented by awards granted under prior plans that are forfeited, expired or canceled without delivery of shares. Awards under the Amended Omnibus Plan may be in the form of restricted stock, restricted stock units, performance-based restricted stock, performance-based stock units, stock options and stock appreciation rights, in accordance with the terms and conditions of the Amended Omnibus Plan. The terms of each award will be determined by the Human Resources, Compensation and Benefits Committee of the Board of Directors or by the Board of Directors.
We have historically issued restricted stock, including non-vested restricted stock, performance-based stock units and stock options. Shares of non-vested restricted stock have the same voting rights as common stock, are entitled to receive dividends and other distributions thereon, and are considered to be currently issued and outstanding. The Company's performance-based stock units are subject to vesting conditions, including meeting specified annual Company performance objectives. Each performance based award recipient could vest 0% to 175% of the target shares granted contingent on the achievement of the Company's financial performance metrics. Performance-based stock units are entitled to dividend equivalents only to the extent certain Company-specific performance goals are met and are entitled to voting rights only upon the issuance of shares after meeting these Company-specific performance goals. Generally, share-based awards vest evenly over three years or cliff-vest after a three-year period; stock options generally have a 10-year term. As of February 2, 2019, approximately 0.2 million nonqualified stock options are outstanding under a predecessor plan and approximately 7.2 million shares remain available for future grants of share-based awards.
Share-based compensation expense for all awards is based on the grant date fair value of the award, net of estimated forfeitures, and is recognized over the requisite service period of the awards. Compensation expense for restricted stock awards and stock options with a service condition is recognized on a straight-line basis over the requisite service period. Compensation expense for performance-based awards with a service condition is recognized ratably for each vesting tranche based on our estimate of the level and likelihood of meeting certain Company-specific performance goals. We estimate the expected forfeiture rate for all share-based awards, and only recognize expense for those shares expected to vest. In determining the portion of the share-based payment award that is ultimately expected to be earned, we derive forfeiture rates based on historical data. In accordance with the authoritative guidance, we revise our forfeiture rates, when necessary, in subsequent periods if actual forfeitures differ from those originally estimated. Total compensation expense related to share-based awards in fiscal 2018, 2017 and 2016 was $19.8 million, $20.7 million and $21.2 million, respectively. The total tax benefit associated with share-based compensation for fiscal 2018, 2017 and 2016 was $5.0 million, $7.6 million and $8.1 million, respectively.
Restricted Stock Awards
Restricted stock activity for fiscal 2018 was as follows:
 
Number of
Shares
 
Weighted
Average Grant
Date Fair
Value
Unvested, beginning of period
2,328,259

 
$
13.08

Granted
1,944,280

 
9.68

Vested
(1,187,553
)
 
12.90

Forfeited
(369,520
)
 
11.64

Unvested, end of period
2,715,466

 
10.92


Total fair value of shares of restricted stock that vested during fiscal 2018, 2017 and 2016 was $10.6 million, $15.6 million and $14.7 million, respectively. The weighted average grant date fair value of restricted stock granted during fiscal 2018, 2017 and 2016 was $9.68$13.23 and $12.38, respectively. As of February 2, 2019, there was $15.6 million of unrecognized share-based compensation expense related to non-vested restricted stock awards. That cost is expected to be recognized over a weighted average remaining period of approximately 1.7 years.
Performance-based Stock Units
Performance-based stock unit activity for fiscal 2018 was as follows:
 
Number of
Shares
 
Weighted
Average Grant
Date Fair
Value
Unvested, beginning of period
690,950

 
$
13.65

Granted
725,300

 
9.87

Vested
(190,777
)
 
13.08

Forfeited
(158,135
)
 
12.65

Unvested, end of period
1,067,338

 
11.40


Total fair value of performance-based stock units that vested during fiscal 2018, 2017 and 2016 was $1.9 million, $4.2 million and $2.9 million, respectively. There was $3.8 million of unrecognized share-based compensation expense related to performance-based stock units expected to vest. That cost is expected to be recognized over a weighted average period of approximately 1.8 years.
Stock Option Awards
We used the Black-Scholes option-pricing model to value our stock options. No stock options have been issued since fiscal 2011 and all have been fully vested since fiscal 2014. Using this option-pricing model, the fair value of each stock option award was estimated on the date of grant. The fair value of the stock option awards, which are subject to pro-rata vesting generally over three years, was expensed on a straight-line basis over the vesting period of the stock options.
Stock option activity for fiscal 2018 was as follows:
 
Number of
Shares
 
Weighted
Average
Exercise
Price
 
Weighted
Average
Remaining
Contractual
Term
 
Aggregate
Intrinsic
Value
(in thousands)
Outstanding, beginning of period
368,745

 
$
12.36

 
 
 
 
Granted

 

 
 
 
 
Exercised
(42,200
)
 
3.60

 
 
 
 
Forfeited or expired
(112,268
)
 
13.39

 
 
 
 
Outstanding, end of period
214,277

 
13.54

 
1.8
 
$

Vested at February 2, 2019
214,277

 
13.54

 
1.8
 

Exercisable at February 2, 2019
214,277

 
13.54

 
1.8
 


Total intrinsic value of options exercised during fiscal 2018, 2017 and 2016 was $0.2 million, $0.01 million and $0.7 million, respectively.
Employee Stock Purchase Plan
We sponsor an employee stock purchase plan (“ESPP”) under which substantially all full-time employees are given the right to purchase shares of our common stock during each of the two specified offering periods each fiscal year at a price equal to 85 percent of the value of the stock immediately prior to the beginning of each offering period. During fiscal 2018, 2017 and 2016, approximately 175,000, 232,000 and 191,000 shares, respectively, were purchased under the ESPP. Cash received from purchases under the ESPP for fiscal 2018 was $1.4 million.
Share Repurchase Program
In fiscal 2018 and fiscal 2017, we repurchased 12.2 million and 2.7 million shares at a total cost of $81.1 million and $27.4 million, respectively, under the Company's $300 million share repurchase program announced in November 2015. As of February 2, 2019, $55.2 million remains under the share repurchase program. However, we have no continuing obligation to repurchase shares under this authorization, and the timing, actual number and value of any additional shares to be purchased will depend on the performance of our stock price, market conditions and other considerations.